29.10.2010 • News

Dow Chemical Q3 Profit Beats, Shares Up

Dow Chemical posted a better-than-expected quarterly profit due to strong sales of chlorine, basic plastic and lubricants, sending shares up 1.5% in early trading.

The results reflect improving consumer demand for a wide range of products made using Dow materials, especially in North America and Europe, where the company had been weak in recent quarters.

Dow Chief Executive Andrew Liveris said he sees "a sustained global economic recovery, led by emerging economies," adding he is bullish on growth in Brazil, Eastern Europe and the Middle East.

The company reported net income of $512 million, or 45 cents per share, compared with $711 million, or 63 cents per share, a year earlier.

Excluding one-time items, Dow earned 54 cents per share. By that measure, analysts had expected earnings of 41 cents per share, according to Thomson Reuters I/B/E/S.

The one-time items include a $35 million charge to further integrate Rohm & Haas, a rival specialty chemicals maker Dow bought in April 2009.

Revenue at the Midland, Mich.-based company rose 6.8% to $12.87 billion. Analysts had expected $12.81 billion.

Volume rose 14% while pricing increased 9%, offsetting higher raw material costs, Dow said.

Dow rival DuPont Co posted a higher-than-expected quarterly profit and raised its 2010 earnings forecast on Tuesday.

 

Company

The Dow Chemical Company

100 Larkin Center
48674 Midland

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read